Follow
R.Hoedemaeker
R.Hoedemaeker
Unknown affiliation
Verified email at planet.nl
Title
Cited by
Cited by
Year
Evaluation of the digital rectal examination as a screening test for prostate cancer
FH Schröder, AB Kruger, J Rietbergen, R Kranse, P Maas, ...
Journal of the National Cancer Institute 90 (23), 1817-1823, 1998
4901998
Prostate cancer detection at low prostate specific antigen
FH Schröder, I Van Der Cruijsen-Koeter, HJ De Koning, AN Vis, ...
The Journal of urology 163 (3), 806-812, 2000
4682000
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial
T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ...
The Journal of urology 185 (1), 121-125, 2011
2972011
The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study
JBW RIETBERGEN, RF HOEDEMAEKER, AEB KRUGER, WIMJ KIRKELS, ...
The Journal of urology 161 (4), 1192-1198, 1999
1601999
Guidelines for processing and reporting of prostatic needle biopsies
TH Van der Kwast, C Lopes, C Santonja, CG Pihl, I Neetens, ...
Journal of clinical pathology 56 (5), 336-340, 2003
1582003
Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer≤ 70 years
CHM Leenen, MGF van Lier, HC van Doorn, ME van Leerdam, SG Kooi, ...
Gynecologic oncology 125 (2), 414-420, 2012
1552012
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)–Section Rotterdam: a comparison of two rounds of screening
R Postma, FH Schröder, GJLH van Leenders, RF Hoedemaeker, AN Vis, ...
European urology 52 (1), 89-97, 2007
1532007
The European randomized study of screening for prostate cancer (ERSPC)
FH Schröder, CH Bangma
British Journal of Urology 79 (S1), 68-71, 1997
134*1997
Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy
AN Vis, MO Boerma, S Ciatto, RF Hoedemaeker, FH Schröder, ...
Urology 56 (4), 617-621, 2000
1032000
Evaluation of prostate needle biopsies in a population‐based screening study: the impact of borderline lesions
RF Hoedemaeker, R Kranse, JBW Rietbergen, AE Boeken Kruger, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1999
971999
Histopathological prostate cancer characteristics at radical prostatectomy after population based screening
RF HOEDEMAEKER, JBW RIETBERGEN, R KRANSE, FH SCHRÖDER, ...
The Journal of urology 164 (2), 411-415, 2000
962000
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features
JC Alers, PJ Krijtenburg, AN Vis, RF Hoedemaeker, MF Wildhagen, ...
The American journal of pathology 158 (2), 399-406, 2001
912001
Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer
T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ...
European urology 57 (5), 821-829, 2010
872010
Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer
JBW RIETBERGEN, AE BOEKEN KRUGER, RF HOEDEMAEKER, ...
The Journal of urology 160 (6 Part 1), 2121-2125, 1998
871998
Pathologic features of prostate cancer found at population-based screening with a four-year interval
RF Hoedemaeker, TH van der Kwast, R Boer, HJ de Koning, M Roobol, ...
Journal of the National Cancer Institute 93 (15), 1153-1158, 2001
832001
Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancer
RF Hoedemaeker, JBW Rietbergen, R Kranse, TH van der Kwast, ...
World journal of urology 15, 339-345, 1997
751997
Staging prostate cancer
RF Hoedemaeker, AN Vis, TH Van Der Kwast
Microscopy research and technique 51 (5), 423-429, 2000
722000
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0–3.9 ng/ml)
AN Vis, RF Hoedemaeker, M Roobol, TH Van Der Kwast, FH Schröder
The Prostate 47 (4), 252-261, 2001
652001
Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70 years of age
A Goverde, MCW Spaander, HC van Doorn, HJ Dubbink, ...
Gynecologic oncology 143 (3), 453-459, 2016
512016
Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors
H van Dekken, JC Alers, IAAJ Damen, KJ Vissers, PJ Krijtenburg, ...
Laboratory investigation 83 (6), 789-796, 2003
492003
The system can't perform the operation now. Try again later.
Articles 1–20